Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Non-Current Deffered Revenue (2020)

Historic Non-Current Deffered Revenue for Burning Rock Biotech (BNR) over the last 1 years, with Q4 2020 value amounting to $40000.0.

  • Burning Rock Biotech's Non-Current Deffered Revenue changed N/A to $40000.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $40000.0, marking a year-over-year change of. This contributed to the annual value of $40000.0 for FY2020, which is N/A changed from last year.
  • Latest data reveals that Burning Rock Biotech reported Non-Current Deffered Revenue of $40000.0 as of Q4 2020.
  • Over the past 5 years, Burning Rock Biotech's Non-Current Deffered Revenue peaked at $40000.0 during Q4 2020, and registered a low of $37000.0 during Q2 2020.